272 related articles for article (PubMed ID: 27389178)
1. Losartan improves cerebrovascular function in a mouse model of Alzheimer's disease with combined overproduction of amyloid-β and transforming growth factor-β1.
Papadopoulos P; Tong XK; Imboden H; Hamel E
J Cereb Blood Flow Metab; 2017 Jun; 37(6):1959-1970. PubMed ID: 27389178
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin IV Receptors Mediate the Cognitive and Cerebrovascular Benefits of Losartan in a Mouse Model of Alzheimer's Disease.
Royea J; Zhang L; Tong XK; Hamel E
J Neurosci; 2017 May; 37(22):5562-5573. PubMed ID: 28476949
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer's disease model.
Ongali B; Nicolakakis N; Tong XK; Aboulkassim T; Papadopoulos P; Rosa-Neto P; Lecrux C; Imboden H; Hamel E
Neurobiol Dis; 2014 Aug; 68():126-36. PubMed ID: 24807206
[TBL] [Abstract][Full Text] [Related]
4. Enalapril Alone or Co-Administered with Losartan Rescues Cerebrovascular Dysfunction, but not Mnemonic Deficits or Amyloidosis in a Mouse Model of Alzheimer's Disease.
Ongali B; Nicolakakis N; Tong XK; Aboulkassim T; Imboden H; Hamel E
J Alzheimers Dis; 2016; 51(4):1183-95. PubMed ID: 26923013
[TBL] [Abstract][Full Text] [Related]
5. Pioglitazone improves reversal learning and exerts mixed cerebrovascular effects in a mouse model of Alzheimer's disease with combined amyloid-β and cerebrovascular pathology.
Papadopoulos P; Rosa-Neto P; Rochford J; Hamel E
PLoS One; 2013; 8(7):e68612. PubMed ID: 23874687
[TBL] [Abstract][Full Text] [Related]
6. Selective benefits of simvastatin in bitransgenic APPSwe,Ind/TGF-β1 mice.
Papadopoulos P; Tong XK; Hamel E
Neurobiol Aging; 2014 Jan; 35(1):203-12. PubMed ID: 23954171
[TBL] [Abstract][Full Text] [Related]
7. Cognitive and cerebrovascular improvements following kinin B1 receptor blockade in Alzheimer's disease mice.
Lacoste B; Tong XK; Lahjouji K; Couture R; Hamel E
J Neuroinflammation; 2013 May; 10():57. PubMed ID: 23642031
[TBL] [Abstract][Full Text] [Related]
8. Transgenic mice overexpressing APP and transforming growth factor-beta1 feature cognitive and vascular hallmarks of Alzheimer's disease.
Ongali B; Nicolakakis N; Lecrux C; Aboulkassim T; Rosa-Neto P; Papadopoulos P; Tong XK; Hamel E
Am J Pathol; 2010 Dec; 177(6):3071-80. PubMed ID: 21088218
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-β1 induces cerebrovascular dysfunction and astrogliosis through angiotensin II type 1 receptor-mediated signaling pathways.
Ongali B; Nicolakakis N; Tong XK; Lecrux C; Imboden H; Hamel E
Can J Physiol Pharmacol; 2018 May; 96(5):527-534. PubMed ID: 29505736
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II, hypertension and angiotensin II receptor antagonism: Roles in the behavioural and brain pathology of a mouse model of Alzheimer's disease.
Wiesmann M; Roelofs M; van der Lugt R; Heerschap A; Kiliaan AJ; Claassen JA
J Cereb Blood Flow Metab; 2017 Jul; 37(7):2396-2413. PubMed ID: 27596834
[TBL] [Abstract][Full Text] [Related]
11. Selective in vivo antagonism of endothelin receptors in transforming growth factor-beta1 transgenic mice that mimic the vascular pathology of Alzheimer's disease.
Papadopoulos P; Ongali B; Hamel E
Can J Physiol Pharmacol; 2010 Jun; 88(6):652-60. PubMed ID: 20628431
[TBL] [Abstract][Full Text] [Related]
12. AT2R's (Angiotensin II Type 2 Receptor's) Role in Cognitive and Cerebrovascular Deficits in a Mouse Model of Alzheimer Disease.
Royea J; Lacalle-Aurioles M; Trigiani LJ; Fermigier A; Hamel E
Hypertension; 2020 Jun; 75(6):1464-1474. PubMed ID: 32362228
[TBL] [Abstract][Full Text] [Related]
13. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin receptor blocker prevented beta-amyloid-induced cognitive impairment associated with recovery of neurovascular coupling.
Takeda S; Sato N; Takeuchi D; Kurinami H; Shinohara M; Niisato K; Kano M; Ogihara T; Rakugi H; Morishita R
Hypertension; 2009 Dec; 54(6):1345-52. PubMed ID: 19805638
[TBL] [Abstract][Full Text] [Related]
15. Memory and cerebrovascular deficits recovered following angiotensin IV intervention in a mouse model of Alzheimer's disease.
Royea J; Martinot P; Hamel E
Neurobiol Dis; 2020 Feb; 134():104644. PubMed ID: 31669735
[TBL] [Abstract][Full Text] [Related]
16. Combined therapy of cilazapril and losartan has no additive effects in ameliorating adriamycin-induced glomerulopathy.
Kim HJ; Ryu JH; Han SW; Park IK; Paik SS; Park MH; Paik DJ; Chung HS; Kim SW; Lee JU
Nephron Physiol; 2004; 97(4):p58-65. PubMed ID: 15331931
[TBL] [Abstract][Full Text] [Related]
17. Neurovascular and Cognitive failure in Alzheimer's Disease: Benefits of Cardiovascular Therapy.
Hamel E; Royea J; Ongali B; Tong XK
Cell Mol Neurobiol; 2016 Mar; 36(2):219-32. PubMed ID: 26993506
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of intranasal losartan in the APP/PS1 transgenic mouse model of Alzheimer disease.
Danielyan L; Klein R; Hanson LR; Buadze M; Schwab M; Gleiter CH; Frey WH
Rejuvenation Res; 2010; 13(2-3):195-201. PubMed ID: 20370487
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice.
Tong XK; Nicolakakis N; Fernandes P; Ongali B; Brouillette J; Quirion R; Hamel E
Neurobiol Dis; 2009 Sep; 35(3):406-14. PubMed ID: 19524673
[TBL] [Abstract][Full Text] [Related]
20. Pleiotropic Benefits of the Angiotensin Receptor Blocker Candesartan in a Mouse Model of Alzheimer Disease.
Trigiani LJ; Royea J; Lacalle-Aurioles M; Tong XK; Hamel E
Hypertension; 2018 Nov; 72(5):1217-1226. PubMed ID: 30354809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
